InterContinental Hotels Group PLC Announces Transaction in Own Shares – June 21
LONDON, UNITED KINGDOM / ACCESSWIRE / June 21, 2024 / The Company announces that on 20 June 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
i3 Energy PLC Announces Reduction of Share Capital - Update
Reduction of Share Capital - Update EASTLEIGH, UNITED KINGDOM / ACCESSWIRE / June 20, 2024 / i3 Energy PLC (AIM:I3E)(TSX:ITE), an independent oil and gas company with assets and operations in the UK and Canada, announces the following update to its proposed reduction of share capital. Proposed Capital Reduction - Next Steps and Timetable Terms used in this announcement have the same meaning given in the shareholder circular of the Company dated 25 March 2024 unless otherwise defined in this announcement.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 20
Purchase of own shares LONDON, UK / ACCESSWIRE / June 20, 2024 / The Company announces that on 19 June 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
InterContinental Hotels Group PLC Announces Transaction in Own Shares – June 19
LONDON, UNITED KINGDOM / ACCESSWIRE / June 19, 2024 / The Company announces that on 18 June 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Angle PLC Announces Posting of 2023 Annual Report & Notice of the AGM
GUILDFORD, SURREY / ACCESSWIRE / June 18, 2024 / ANGLE plc ("the Company") (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, announces that the audited Annual Report and Financial Statements for the year ended 31 December 2023, and the Notice of Annual General Meeting within it, have been posted to shareholders, and are available on the Company's website. The Annual General Meeting will now be held at 12:00 pm on Thursday 11 July 2024 at the Surrey Technology Centre, Surrey Research Park, Guildford, Surrey GU2 7YG.
i3 Energy PLC Announces Holding(s) in Company
EASTLEIGH, UNITED KINGDOM / ACCESSWIRE / June 18, 2024 / i3 Energy PLC (AIM:I3E)(TSX:ITE) TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDHXPJ60 Issuer Name I3 ENERGY PLC UK or Non-UK Issuer UK 2.
Trident Royalties PLC Announces Holding(s) in Company
LONDON, UNITED KINGDOM / ACCESSWIRE / June 18, 2024 / TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : TRIDENT ROYALTIES PLC 1b.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 18
Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / June 18, 2024 / The Company announces that on 17 June 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Ecora Resources PLC Announces Director/PDMR Shareholding
LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) ("Ecora" or the "Company") has received notification of the following transactions by Marc Bishop Lafleche, Chief Executive Officer, Andrew Webb, Non-Executive Chairman and Kevin Flynn, Chief Financial Officer. On 13 June 2024, Mr.
Poolbeg Pharma PLC Announces Result of AGM
Results of Annual General Meeting LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) ‘Poolbeg' or the ‘Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that all resolutions put to shareholders at the Company's Annual General Meeting held earlier today were duly passed. Enquiries Poolbeg Pharma Plc Jeremy Skillington, CEO Ian O'Connell, CFO +44 (0) 207 183 1499 Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker) Geoff Nash, Charlie Beeson, Nigel Birks, Harriet Ward (ECM) +44 (0) 207 220 0500 Shore Capital Stockbrokers Ltd (Joint Broker) David Coaten, Harry Davies-Ball (Corporate Advisory), Malachy McEntyre, Isobel Jones (Corporate Broking) +44 (0) 207 408 4090 J&E Davy (Joint Broker) Anthony Farrell, Niall Gilchrist +353 (0) 1 679 6363 Optimum Strategic Communications Nick Bastin, Vici Rabbetts, Elena Bates +44 (0) 208 078 4357 [email protected] About Poolbeg Pharma Poolbeg Pharma plc is committed to the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, with a growing emphasis on rare and orphan diseases.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 17
Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / The Company announces that on 14 June 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Hemogenyx Pharmaceuticals PLC Announces Operations Update
Operations Update LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress. 1. HEMO-CAR-T Clinical Trials Progress: Additional Clinical Trial Site: The Company has added an additional prestigious US medical center to its list of clinical trial sites.
